Am. J. Respir. Crit. Care Med., Volume 162, Number 6, December 2000, 2079-2086

Comparison of Cost-Effectiveness of Tuberculosis Screening of Close Contacts and Foreign-Born Populations

KABERI DASGUPTA, KEVIN SCHWARTZMAN, ROBERT MARCHAND, TERRY NAN TENNENBAUM, PAUL BRASSARD, and DICK MENZIES

Respiratory Epidemiology Unit, McGill University; Montreal Chest Institute, Direction de la Santé Publique, Régie Régionale de la Santé et des Services Sociaux de Montreal-Centre, Montreal; and Centre Hospitalier Hôtel-Dieu d'Amos, Amos, Quebec, Canada

Although tuberculosis (TB) screening of immigrants has been conducted for over 50 yr in many industrialized countries, its cost- effectiveness has never been evaluated. We prospectively compared the yield and cost-effectiveness of two immigrant TB screening programs, using close-contact investigation and passive case detection. Study subjects included all immigration applicants undergoing radiographic screening, already arrived immigrants requiring surveillance for inactive TB, and close contacts of active cases resident in Montreal, Quebec, Canada, who were referred from June 1996 to June 1997 to the Montreal Chest Institute (MCI), a referral center specializing in respiratory diseases. For all subjects seen, demographic data, investigations, diagnoses, and therapy were abstracted from administrative data bases and medical charts. Estimated costs of detecting and treating each prevalent active case and preventing future active cases, based on federal and provincial health reimbursement schedules, were compared with the costs for passively diagnosed cases of active TB. Over a period of 1 yr, the three programs detected 27 cases of prevalent active TB and prevented 14 future cases. As compared with passive case detection, close-contact investigation resulted in net savings of $815 for each prevalent active case detected and treated and of $2,186 for each future active case prevented. The incremental cost to treat each case of prevalent active TB was $39,409 for applicant screening and $24,225 for surveillance, and the cost of preventing each case was $33,275 for applicants and $65,126 for surveillance. Close-contact investigation was highly cost effective and resulted in net savings. Immigrant applicant screening and surveillance programs had a significant impact but were much less cost effective, in large part because of substantial operational problems.

This article has been cited by other articles:

				K. Borgen, B. Koster, H. Meijer, V. Kuyvenhoven, M. van der Sande, and F. Cobelens Evaluation of a large-scale tuberculosis contact investigation in the Netherlands Eur. Respir. J., August 1, 2008; 32(2): 419 - 425. [Abstract] [Full Text] [PDF]

				C. Erkens, E. Slump, M. Kamphorst, S. Keizer, P. J. H. J. van Gerven, R. Bwire, M. Berkel, M. W. Borgdorff, and S. Verver Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants Eur. Respir. J., July 1, 2008; 32(1): 153 - 161. [Abstract] [Full Text] [PDF]

				U. R. Dahle, V. Eldholm, B. A. Winje, T. Mannsaker, and E. Heldal Impact of Immigration on the Molecular Epidemiology of Mycobacterium tuberculosis in a Low-Incidence Country Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 930 - 935. [Abstract] [Full Text] [PDF]

				V. J. Flaherman, T. C. Porco, E. Marseille, and S. E. Royce Cost-effectiveness of Alternative Strategies for Tuberculosis Screening Before Kindergarten Entry Pediatrics, July 1, 2007; 120(1): 90 - 99. [Abstract] [Full Text] [PDF]

				R. Diel, A. Nienhaus, and R. Loddenkemper Cost-effectiveness of Interferon-{gamma} Release Assay Screening for Latent Tuberculosis Infection Treatment in Germany Chest, May 1, 2007; 131(5): 1424 - 1434. [Abstract] [Full Text] [PDF]

				R. Diel, A. Nienhaus, C. Lange, and T. Schaberg Cost-optimisation of screening for latent tuberculosis in close contacts Eur. Respir. J., July 1, 2006; 28(1): 35 - 44. [Abstract] [Full Text] [PDF]

				P. Wrighton-Smith and J-P. Zellweger Direct costs of three models for the screening of latent tuberculosis infection Eur. Respir. J., July 1, 2006; 28(1): 45 - 50. [Abstract] [Full Text] [PDF]

				P. Brassard, C. Steensma, L. Cadieux, and L. C. Lands Evaluation of a School-Based Tuberculosis-Screening Program and Associate Investigation Targeting Recently Immigrated Children in a Low-Burden Country Pediatrics, February 1, 2006; 117(2): e148 - e156. [Abstract] [Full Text] [PDF]

				American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1169 - 1227. [Full Text] [PDF]

				K. Schwartzman, O. Oxlade, R. G. Barr, F. Grimard, I. Acosta, J. Baez, E. Ferreira, R. E. Melgen, W. Morose, A. C. Salgado, et al. Domestic Returns from Investment in the Control of Tuberculosis in Other Countries N. Engl. J. Med., September 8, 2005; 353(10): 1008 - 1020. [Abstract] [Full Text] [PDF]

				R. Diel, A. Nienhaus, and T. Schaberg Cost-effectiveness of isoniazid chemoprevention in close contacts Eur. Respir. J., September 1, 2005; 26(3): 465 - 473. [Abstract] [Full Text] [PDF]

				S. Verver, J. H. van Loenhout-Rooyackers, R. Bwire, J. A. C. M. Annee-van Bavel, H. J. M. de Lange, P. J. H. J. van Gerven, and M. W. Borgdorff Tuberculosis infection in children who are contacts of immigrant tuberculosis patients Eur. Respir. J., July 1, 2005; 26(1): 126 - 132. [Abstract] [Full Text] [PDF]

				K. Dasgupta and D. Menzies Cost-effectiveness of tuberculosis control strategies among immigrants and refugees Eur. Respir. J., June 1, 2005; 25(6): 1107 - 1116. [Abstract] [Full Text] [PDF]

				D. Menzies, M.-J. Dion, B. Rabinovitch, S. Mannix, P. Brassard, and K. Schwartzman Treatment Completion and Costs of a Randomized Trial of Rifampin for 4 Months versus Isoniazid for 9 Months Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 445 - 449. [Abstract] [Full Text] [PDF]

				D. Menzies Screening immigrants to Canada for tuberculosis: Chest radiography or tuberculin skin testing? Can. Med. Assoc. J., November 11, 2003; 169(10): 1035 - 1036. [Full Text]

				M. Meyer, P. Clarke, and A. W. O'Regan Utility of the Lateral Chest Radiograph in the Evaluation of Patients With a Positive Tuberculin Skin Test Result Chest, November 1, 2003; 124(5): 1824 - 1827. [Abstract] [Full Text] [PDF]

				S. M. Marks, K. Ijaz, M. F. Iademarco, T. Sterling, S. S. Munsiff, T. R. Frieden, D. Menzies, K. Schwartzman, E. R. Jenny-Avital, K. Khan, et al. Management of Latent Tuberculosis Infection in Immigrants N. Engl. J. Med., March 27, 2003; 348(13): 1289 - 1292. [Full Text] [PDF]

				M.-J. Dion, P. Tousignant, J. Bourbeau, D. Menzies, and K. Schwartzman Measurement of Health Preferences among Patients with Tuberculous Infection and Disease Med Decis Making, October 1, 2002; 22(5_suppl): S102 - S114. [Abstract] [PDF]

				S. Kulaga, M. Behr, K. Musana, J. Brinkman, D. Menzies, P. Brassard, D. Kunimoto, T.-N. Tannenbaum, L. Thibert, L. Joseph, et al. Molecular epidemiology of tuberculosis in Montreal Can. Med. Assoc. J., August 1, 2002; 167(4): 353 - 354. [Full Text] [PDF]

				K. Schwartzman Latent tuberculosis infection: old problem, new priorities Can. Med. Assoc. J., March 1, 2002; 166(6): 759 - 761. [Full Text] [PDF]

				J. C. Mohle-Boetani and J. Flood Contact Investigations and the Continued Commitment to Control Tuberculosis JAMA, February 27, 2002; 287(8): 1040 - 1042. [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				D. Menzies Controlling Tuberculosis among Foreign Born within Industrialized Countries . Expensive Band-Aids Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 914 - 915. [Full Text] [PDF]

				Z. Taylor and R. J. O'Brien Tuberculosis Elimination . Are We Willing to Pay the Price? Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 1 - 2. [Full Text]